Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of Abciximab in Patients With AMI Undergoing PCI After High Dose Clopidogrel Pretreatment (BRAVE 3)

NCT00133250 is registered in ClinicalTrials.gov with Deutsches Herzzentrum Muenchen as lead sponsor.

NCT NCT00133250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00133250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of Abciximab in Patients With AMI Undergoing PCI After High Dose Clopidogrel Pretreatment (BRAVE 3)
Lead sponsor
Deutsches Herzzentrum Muenchen
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2003
Completion date
March 31, 2008
Enrollment
800 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction